The Hsp110 molecular chaperone is increasingly being recognized as a potent regulator of amyloidogenesis as well as a potential pathogenic modifier for multiple protein misfolding disorders including cystic fibrosis, Alzheimer?s disease and Huntington?s disease (HD). However, few systematic studies have been carried out on metazoan Hsp110 to examine its physiological roles, particularly in long-lived neurons that are more susceptible to protein misfolding and aggregate formation, largely due to lack of suitable metazoan model. In addition, Hsp110 has been determined at the biochemical level to function both as a chaperone ?holdase? and as a Hsp70 nucleotide exchange factor (NEF). However, how these two distinct activities contribute to its neuronal protective role is unknown. In this R21 application, we propose to generate Drosophila lines with designed mutations in the sole fly Hsp110 ortholog (dHsp110) that specifically abolish holdase or NEF activities, and use established Drosophila HD models to test the hypothesis that Hsp110 acts as an activator of Hsp70 cycling in concert with Hsp40, and/or as a stand-alone chaperone holdase to sequester amyloidogenic proteins and prevent aggregation and associated toxicity. Completion of this project will establish the feasibility of future pharmacological exploitation of Hsp110 in the nervous system to combat morbidity and mortality arising from proteopathies in the aging population.

Public Health Relevance

Neurodegenerative disorders such as Alzheimer?s, Parkinson?s, Lou Gehrig?s and Huntington?s diseases are debilitating health problems affecting a growing number of older Americans. While human neurons possess powerful systems for repairing the cellular damage that causes these diseases, the mechanisms by which they do so are complicated and poorly understood. This project will bring together major developments in two simple experimental model systems, fruit flies and yeast, to probe these questions and pave the way for future drugs to treat and prevent these terrible diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21AG051046-01A1
Application #
9180542
Study Section
Membrane Biology and Protein Processing Study Section (MBPP)
Program Officer
Wise, Bradley C
Project Start
2016-08-01
Project End
2018-04-30
Budget Start
2016-08-01
Budget End
2017-04-30
Support Year
1
Fiscal Year
2016
Total Cost
Indirect Cost
Name
University of Texas Health Science Center Houston
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
800771594
City
Houston
State
TX
Country
United States
Zip Code
77225